Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3

被引:94
作者
Rauchenberger, R
Borges, E
Thomassen-Wolf, E
Rom, E
Adar, R
Yaniv, Y
Malka, M
Chumakov, I
Kotzer, S
Resnitzky, D
Knappik, A
Reiffert, S
Prassler, J
Jury, K
Waldherr, D
Bauer, S
Kretzschmar, T
Yayon, A
Rothe, C
机构
[1] ProChon Biotech Ltd, IL-76114 Rehovot, Israel
[2] MorphoSys AG, D-82152 Martinsried, Germany
[3] Weizmann Inst Sci, IL-76100 Rehovot, Israel
关键词
D O I
10.1074/jbc.M303164200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human combinatorial antibody library Fab 1 (HuCAL(R)-Fab 1) was generated by transferring the heavy and light chain variable regions from the previously constructed single-chain Fv library (Knappik, A., Ge, L., Honegger, A., Pack, P., Fischer, M., Wellnhofer, G., Hoess, A., Wolle, J., Pluckthun, A., and Virnekas, B. (2000) J. Mol. Biol. 296, 57-86), diversified in both complementarity-determining regions 3 into a novel Fab display vector, yielding 2.1 x 10(10) different antibody fragments. The modularity has been retained in the Fab display and screening plasmids, ensuring rapid conversion into various antibody formats as well as antibody optimization using prebuilt maturation cassettes. HuCAL(R)-Fab 1 was challenged against the human fibroblast growth factor receptor 3, a potential therapeutic antibody target, against which, to the best of our knowledge, no functional antibodies could be generated so far. A unique screening mode was designed utilizing recombinant functional proteins and cell lines differentially expressing fibroblast growth factor receptor isoforms diversified in expression and receptor dependence. Specific Fab fragments with subnanomolar affinities were isolated by selection without any maturation steps as determined by fluorescence flow cytometry. Some of the selected Fab fragments completely inhibit target-mediated cell proliferation, rendering them the first monoclonal antibodies against fibroblast growth factor receptors having significant function blocking activity. This study validates HuCAL(R)-Fab 1 as a valuable source for the generation of target-specific antibodies for therapeutic applications.
引用
收藏
页码:38194 / 38205
页数:12
相关论文
共 90 条
[81]   PRODUCTION OF ANTIFIBROBLAST GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODIES BY INVITRO IMMUNIZATION [J].
VENKATESWARAN, S ;
BLANCKAERT, V ;
SCHELLING, M .
HYBRIDOMA, 1992, 11 (06) :729-739
[82]   TRINUCLEOTIDE PHOSPHORAMIDITES - IDEAL REAGENTS FOR THE SYNTHESIS OF MIXED OLIGONUCLEOTIDES FOR RANDOM MUTAGENESIS [J].
VIRNEKAS, B ;
GE, LM ;
PLUCKTHUN, A ;
SCHNEIDER, KC ;
WELLNHOFER, G ;
MORONEY, SE .
NUCLEIC ACIDS RESEARCH, 1994, 22 (25) :5600-5607
[83]   Mutagenesis of a flexible loop in streptavidin leads to higher affinity for the Strep-tag II peptide and improved performance in recombinant protein purification [J].
Voss, S ;
Skerra, A .
PROTEIN ENGINEERING, 1997, 10 (08) :975-982
[84]   Subcellular and developmental expression of alternatively spliced forms of fibroblast growth factor 14 [J].
Wang, Q ;
McEwen, DG ;
Ornitz, DM .
MECHANISMS OF DEVELOPMENT, 2000, 90 (02) :283-287
[85]   FGFR activation in skeletal disorders: Too much of a good thing [J].
Webster, MK ;
Donoghue, DJ .
TRENDS IN GENETICS, 1997, 13 (05) :178-182
[86]  
WEIDNER KM, 1992, J BIOL CHEM, V267, P10281
[87]   Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy [J].
Witte, L ;
Hicklin, DJ ;
Zhu, ZP ;
Pytowski, B ;
Kotanides, H ;
Rockwell, P ;
Böhlen, P .
CANCER AND METASTASIS REVIEWS, 1998, 17 (02) :155-161
[88]   LENGTH DISTRIBUTION OF CDRH3 IN ANTIBODIES [J].
WU, TT ;
JOHNSON, G ;
KABAT, EA .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1993, 16 (01) :1-7
[89]  
Yang XD, 1999, CANCER RES, V59, P1236
[90]   IMPROVED M13 PHAGE CLONING VECTORS AND HOST STRAINS - NUCLEOTIDE-SEQUENCES OF THE M13MP18 AND PUC19 VECTORS [J].
YANISCHPERRON, C ;
VIEIRA, J ;
MESSING, J .
GENE, 1985, 33 (01) :103-119